Company Cash Funds: kyvernatx.com (KYTX)

kyvernatx.com - graphic logo of issuer KYTX

Kyverna Therapeutics management is effectively attracting investment to apply oncology expertise to the treatment of autoimmune pathologies. The cash level indicator shows peak values, after which this parameter remains at 0.17. The business relies on a closed-loop CAR-T therapy production cycle, integrating medical centers into its network. Stability is ensured by the absence of sanction risks within the US legal framework.

Company Cash and Cash Equivalents: Kyverna Therapeutics Inc. (KYTX) for 02/21/2024 - 11/21/2026

Financial and market metric breakdowns for Kyverna (KYTX)

- company stock exchange capitalization indicators:
Summary company analysis:Kyverna Therapeutics
Product sample of Kyverna Therapeutics Inc.

This indicator reflects the total volume of liquid assets available for operational management without resorting to external financing. The metric is calculated as the sum of cash and cash equivalents, allowing for an assessment of the safety margin against a potential cash crunch. Analyzing the history of cash balances helps diagnose resource depletion in a timely manner. For Kyverna Therapeutics (KYTX), this is critical while undergoing rigorous FDA oversight regarding the development of CAR-T therapy.

Direct competitors

Company Cash Volume ARGX|BioNTech - Company Cash and Cash Equivalents|Company Cash Volume ABVX (abivax.com)|Company Cash Balance ADMA|Protagonist Therapeutics, Inc. - Company Cash Volume|Company Cash Reserve Immunovant, Inc.|KNSA: Company Cash Volume|GRFS - Company Liquid Assets|ADPT (Adaptive Biotechnologies Inc.) - Company Cash Volume|CLDX: Company Cash Balance|Company Cash Funds Aurinia Pharmaceuticals Inc. (AUPH)|Company Cash Funds BCRX (BioCryst Pharmaceuticals Inc)|Company Cash Volume VERA (Vera Corp)|Company Total Cash Amount DNTH (Dianthus Therapeutics)|PHVS - Company Cash Funds|ABCL: Company Cash Funds|TRML: Company Cash Volume|Company Cash on Hand Precigen, Inc.|Company Cash on Hand PHAR|Nektar Therapeutics - Company Total Cash Volume|Company Cash Funds Upstream Bio Corp (UPB)|Company Cash on Hand Zenas Biopharma ZBIO|Company Cash Funds Immunome Bio IMNM|GOSS: Company Cash and Cash Equivalents|kalvista.com - Company Cash Volume|SEPN (septerna.com) - Company Cash and Cash Equivalents|PVLA (Pieris Pharmaceuticals) - Company Cash on Hand|Savara - Company Cash Balance|RIGL (Rigel Corp) - Company Cash Volume|Company Cash Volume AnaptysBio Corp|Company Cash Funds astriatx.com (ATXS)|Company Cash on Hand enGene ENGN|Company Cash Funds RAPT Therapeutics, Inc. RAPT|JBIO - Company Cash on Hand|Aclaris Therapeutics Inc. - Company Cash Volume|Company Liquid Assets Tiziana Life Sciences TLSA|CABA: Company Cash Volume|Company Cash and Cash Equivalents VTYX|Company Cash on Hand THTX|Company Cash Volume Avalo Therapeutics Inc.|Company Cash Funds Eledon (ELDN)|Company Cash Volume Agenus Inc (AGEN)|Company Cash Volume CLYM (climbbio.com)|ZURA - Company Cash on Hand|atyrpharma.com - Company Cash Volume|ADAG (adagene.com) - Company Cash and Cash Equivalents|IMA (Ikena Oncology) - Company Cash on Hand|Company Cash on Hand Shattuck Labs Inc|EQ (Equillium Inc) - Company Cash Volume|CNTB: Company Cash Balance|Company Cash Volume IMUX|ATRA (Atara Biotherapeutics, Inc.) - Company Cash Balance|Company Cash Volume IFRX (inflarx.de)|X4 Pharmaceuticals - Company Cash Funds|Adicet Bio, Inc. - Company Cash Volume|CELU (celularity.com) - Company Cash and Cash Equivalents|INMB: Company Cash Volume|Barinthus Biotherapeutics PLC (BRNS) - Company Cash Volume|Company Cash Funds Kezar Life Sciences|Company Cash on Hand SAB Biotherapeutics (SABS)|Company Cash Funds Akari Therapeutics Plc (AKTX)|Company Cash on Hand Enlivex Therapeutics, Ltd. ENLV|Q32 Bio Inc. - Company Cash on Hand|GeoVax Labs (GOVX) - Company Cash Reserve|edesabiotech.com - Company Cash Volume|Company Liquid Assets iBio Corp IBIO|CARM: Company Cash Volume|xtlbio.com (XTLB) - Company Cash Volume|BOLT (Bolt Biotherapeutics) - Company Cash Volume|Company Cash on Hand HCW Biologics (HCWB)|Company Cash on Hand APVO (Aptevo Therapeutics)|AIM - Company Cash Reserve|Aditxt - Company Cash on Hand|Company Cash Position gribio.com|XRTX: Company Cash on Hand|Company Cash Balance HIND (Vyome Holdings)|REVB (Revelation Bio) - Company Cash on Hand|Indaptus Corp (INDP) - Company Cash Volume|Company Cash Funds scinai.com|Company Cash on Hand CalciMedica, Inc. (CALI)|Company Cash Funds Affimed NV (AFMD)|Company Cash Funds ALLK (Allakos Inc)|Company Cash Funds HOOKIPA Pharma, Inc. HOOK|Company Liquid Assets IGM Bio (IGMS)|iTeos Pharma - Company Cash Volume|Company Liquid Assets oceanbiomedical.com OCEA|TC BioPharm (TCBP) - Company Cash Funds|Company Cash and Cash Equivalents THRD